Medha Munshi, MD
Geriatric Medicine · Boston, MANPI 1699733659
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $47,004 of the $64,429 with a category attached, or 73.0%. 8 manufacturers reported payments, led by Abbott at 42.7% of the total. 2025 is the largest year on record at $22,635, more than ten times the $1,874 reported in 2019. Among geriatric medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $692.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$28K
- Sanofi-aventis U.S. LLC$27K
- Medtronic$8K
- Eli Lilly$2K
- Tandem Diabetes Care, Inc.$114
- Insulet Corporation$99
- plus $103 from 2 others
Across 18 payments — averaging $12,091 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dexcom, Inc.$213K
- Sanofi-aventis U.S. LLC$4K
What the payments were for
- Consulting fees$47,00473%
- Speaking & faculty fees$6,48110%
- Grants$570%
- Travel & lodging$6,97511%
- Food & beverage$3,9046%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 59 | $27,528 |
| Sanofi-aventis U.S. LLC | 17 | $26,877 |
| Medtronic | 12 | $8,133 |
| Eli Lilly | 1 | $1,575 |
| Tandem Diabetes Care, Inc. | 1 | $114 |
| Insulet Corporation | 1 | $99 |
| Dexcom, Inc. | 1 | $94 |
| Lilly USA, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$19,052
- FREESTYLE LIBRE 3$15,853
- TOUJEO$7,752
- MINIMED 780G$1,254
- t:slim X2 Insulin Pump with Control-IQ$114
How this compares
$64,429 in reported general payments places this provider in the 95th percentile of 156 geriatric medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $133,095 |
| TrulicityDulaglutide | 54 | $71,464 |
| JardianceEmpagliflozin | 56 | $46,050 |
| JanuviaSitagliptin Phosphate | 41 | $41,167 |
| Tresiba Flextouch U-100Insulin Degludec | 46 | $40,997 |
| EliquisApixaban | 36 | $33,117 |
| TradjentaLinagliptin | 41 | $30,000 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 20 | $26,406 |
| FarxigaDapagliflozin Propanediol | 21 | $22,943 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $9,990 |
| MyrbetriqMirabegron | 13 | $5,648 |
| Novolin N FlexpenInsulin Nph Human Isophane | 20 | $3,957 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 28 | $2,460 |
| Metoprolol Succinate | 87 | $2,379 |
| Metformin Hcl | 118 | $1,806 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $8 | $71,46454 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $26,877 | $26,40620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 156 geriatric medicine providers in Massachusetts.
Other geriatric medicine in Boston
- Douglas KielBoston$5K
- Benjamin HanBoston$1K
- Amanda HernandezBoston$1K
- Juan Nunez MedinaBoston$867
- Ardeshir HashmiBoston$395
- Ronald GomesBoston$339
- Robert SchreiberBoston$185
- Afia MirzaBoston$185
- Esteban Franco GarciaBoston$144
- Stephanie PagliucaBoston$121
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.